Close
Help




JOURNAL

Cancer Informatics

Profiling Age-Related Epigenetic Markers of Stomach Adenocarcinoma in Young and Old Subjects

Submit a Paper


Cancer Informatics 2015:14 47-54

Original Research

Published on 20 Apr 2015

DOI: 10.4137/CIN.S16912


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Cancer Informatics

Abstract

The purpose of our study is to identify epigenetic markers that are differently expressed in the stomach adenocarcinoma (STAD) condition. Based on data from The Cancer Genome Atlas (TCGA), we were able to detect an age-related difference in methylation patterns and changes in gene and miRNA expression levels in young (n = 14) and old (n = 70) STAD subjects. Our analysis identified 323 upregulated and 653 downregulated genes in old STAD subjects. We also found 76 miRNAs with age-related expression patterns and 113 differentially methylated genes (DMGs), respectively. Our further analysis revealed that significant upregulated genes (n = 35) were assigned to the cell cycle, while the muscle system process (n = 27) and cell adhesion-related genes (n = 57) were downregulated. In addition, by comparing gene and miRNA expression with methylation change, we identified that three upregulated genes (ELF3, IL1β, and MMP13) known to be involved in inflammatory responses and cell growth were significantly hypomethylated in the promoter region. We further detected target candidates for age-related, downregulated miRNAs (hsa-mir-124–3, hsa-mir-204, and hsa-mir-125b-2) in old STAD subjects. This is the first report of the results from a study exploring age-related epigenetic biomarkers of STAD using high-throughput data and provides evidence for a complex clinicopathological condition expressed by the age-related STAD progression.



Downloads

PDF  (1.90 MB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

Supplementary Files 1  (2.31 MB ZIP FORMAT)

BibTex citation   (BIBDESK, LATEX)

XML

PMC HTML


Sharing


What Your Colleagues Say About Cancer Informatics
Cancer Informatics has become an increasingly important source for research in the methodology of cancer genomics and the novel use of informatics technology. I have been impressed by the journal's contents and have been very gratified by the number of accesses to my recent publication. Cancer Informatics has filled an important gap in cancer research journals.
Dr Richard Simon (Chief, Biometric Research Branch, National Cancer Institute, USA )
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube